Dr. Mitalipov to give Breaking News Lecture in November

Foundation for Reproductive Medicine (FRM), the non-profit organization that organizes the annual Translational Reproductive Biology and Clinical Reproductive Endocrinology Conference in New York City, announced today that Shoukhrat Mitalipov, PhD, will give the Breaking News Lecture discussing successful genetic editing of human embryos at the upcoming conference in November.

Dr. Mitalipov, Professor and Director of the Center for Embryonic Cell and Gene Therapy at the Oregon Health and Science University, and a long-time friend and collaborator of CHR’s, just published a paper in the journal Nature describing the first successful human gene editing in the United States. Dr. Mitalipov’s team used a gene editing tool called CRISPR-Cas9 to correct the genetic error at the time of fertilization of the egg to prevent the inheritance of a single-gene heart condition.

Read the full press release here.

Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned reproductive endocrinologist, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.